Teacher Retirement System of Texas bought a new position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 32,908 shares of the company's stock, valued at approximately $888,000. Teacher Retirement System of Texas owned approximately 0.17% of USANA Health Sciences as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the business. Exchange Traded Concepts LLC grew its position in USANA Health Sciences by 7.1% in the first quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock worth $248,000 after acquiring an additional 606 shares in the last quarter. Versant Capital Management Inc grew its position in USANA Health Sciences by 542.5% in the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after acquiring an additional 971 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in USANA Health Sciences by 15.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,234 shares of the company's stock worth $260,000 after acquiring an additional 985 shares in the last quarter. Franklin Resources Inc. grew its position in USANA Health Sciences by 4.8% in the fourth quarter. Franklin Resources Inc. now owns 22,070 shares of the company's stock worth $792,000 after acquiring an additional 1,020 shares in the last quarter. Finally, Parallel Advisors LLC boosted its holdings in shares of USANA Health Sciences by 8,141.2% during the 1st quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock worth $38,000 after buying an additional 1,384 shares during the period. 54.25% of the stock is owned by institutional investors.
Insider Buying and Selling at USANA Health Sciences
In other news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction on Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 12,013 shares of company stock valued at $360,149. Corporate insiders own 0.63% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Read Our Latest Analysis on USNA
USANA Health Sciences Price Performance
Shares of NYSE USNA traded down $0.67 during trading hours on Thursday, hitting $30.66. 123,029 shares of the stock were exchanged, compared to its average volume of 141,290. The company's 50 day moving average is $30.59 and its 200 day moving average is $30.28. The firm has a market capitalization of $570.87 million, a P/E ratio of 16.85, a P/E/G ratio of 1.00 and a beta of 0.64. USANA Health Sciences, Inc. has a one year low of $23.10 and a one year high of $48.85.
USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, April 22nd. The company reported $0.73 EPS for the quarter, beating the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million during the quarter, compared to analysts' expectations of $243.08 million. USANA Health Sciences had a net margin of 3.98% and a return on equity of 8.94%. During the same period in the prior year, the company earned $0.86 EPS. Research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.
USANA Health Sciences Profile
(
Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories

Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.